GSK3B and neurodegenerative disease: Their findings suggest that LPLI protects against STS-induced apoptosis by disrupting the Bax translocation process via the PI3K/Akt/GSK-3β pathway, making it a potential therapy for neurodegenerative diseases linked to GSK-3β activity.